3D SYSTEMS CORP
Business
3D SYSTEMS CORP provides comprehensive 3D printing and digital manufacturing solutions, offering hardware, materials, software and related services. Its main products and services include 3D printers for plastics, metals and bioprinting, proprietary materials, digital design and manufacturing software, maintenance, advanced manufacturing and applications engineering services, and regenerative medicine and organs-on-chips R&D. The company operates through two primary segments: Healthcare Solutions (dental, medical devices, personalized health and regenerative medicine) and Industrial Solutions (aerospace, defense, transportation and general manufacturing). It sells globally across the Americas, EMEA and APAC via direct sales, channel partners and distributors.
Summary from filing dated 2025-03-27
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenue | 387 | 440 | 488 | 538 | 616 | |
| Total cost of sales | 256 | 276 | 292 | 324 | 352 | |
| Gross profit | 131 | 164 | 196 | 214 | 264 | |
| Selling, general and administrative | 161 | 210 | 210 | 244 | 228 | |
| Research and development | 65 | 86 | 89 | 87 | 69 | |
| Asset impairment charges | 760,000 | 145 | 303 | 0 | — | |
| Total operating expenses | 227 | 442 | 602 | 331 | 297 | |
| Loss from operations | −96 | −277 | −406 | −117 | −33 | |
| Foreign exchange gain (loss), net | 4 | 2 | −5 | −4 | — | |
| Interest income | 4 | 7 | 20 | 9 | — | |
| Interest expense | −5 | −3 | −3 | −3 | — | |
| Gain on disposition | 140 | 0 | 0 | — | — | |
| Other income, net | 4 | 20 | 32 | −6 | — | |
| Total non-operating income | 146 | 27 | 44 | −4 | 353 | |
| Net income (loss) before income taxes | 50 | −250 | −362 | −121 | 320 | |
| (Provision) benefit for income taxes | −15 | −2 | 641,000 | −2 | 3 | |
| Loss on equity method investment, net of income taxes | −5 | −3 | −1 | 0 | 0 | |
| Net income (loss) before redeemable non-controlling interest | 30 | −256 | −363 | −123 | 322 | |
| Less: net loss attributable to redeemable non-controlling interest | 0 | 0 | −265,000 | −238,000 | 0 | |
| Net income (loss) attributable to 3D Systems Corporation | 30 | −256 | −363 | −123 | 322 | |
| Basic (in dollars per share) | 0.23 | −1.94 | −2.79 | −0.96 | 2.62 | |
| Diluted (in dollars per share) | 0.19 | −1.94 | −2.79 | −0.96 | 2.55 | |
| Basic (in shares) | 129 | 132 | 130 | 128 | 123 | |
| Weighted average shares - Diluted (in shares) | 176 | 132 | 130 | 128 | 126 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 96 | 171 | 332 | 388 | 790 | |
| Accounts receivable, net of reserves $3,608 and $2,433 | 84 | 101 | 101 | 94 | 107 | |
| Inventories | 127 | 119 | 152 | 138 | 93 | |
| Prepaid expenses and other current assets | 40 | 34 | 43 | 34 | 43 | |
| Assets held for sale | 0 | 3 | 0 | — | 0 | |
| Total current assets | 347 | 429 | 628 | 834 | 1,032 | |
| Property and equipment, net | 49 | 51 | 64 | 58 | 57 | |
| Intangible assets, net | 17 | 18 | 63 | 90 | 46 | |
| Goodwill | 16 | 15 | 116 | 385 | 346 | |
| Operating lease right-of-use assets | 45 | 51 | 58 | 40 | — | |
| Finance lease right-of-use assets | 8 | 9 | 12 | 3 | — | |
| Long-term deferred income tax assets | 3 | 2 | 4 | 7 | 5 | |
| Other assets | 38 | 35 | 45 | 29 | 17 | |
| Total assets | 522 | 609 | 991 | 1,447 | 1,549 | |
| Current portion of long-term debt, net of deferred financing costs | 4 | 0 | — | — | 0 | |
| Current operating lease liabilities | 12 | 10 | 10 | 8 | — | |
| Accounts payable | 41 | 42 | 50 | 54 | 57 | |
| Accrued and other liabilities | 47 | 45 | 49 | 56 | 77 | |
| Customer deposits and deferred revenue | 17 | 32 | 30 | 26 | 28 | |
| Liabilities held for sale | 0 | 10 | 0 | — | 0 | |
| Total current liabilities | 121 | 139 | 147 | 152 | 178 | |
| Long-term debt, net of deferred financing costs | 86 | 212 | 319 | 450 | 447 | |
| Long-term operating lease liabilities | 45 | 53 | 57 | 38 | — | |
| Long-term deferred income tax liabilities | 3 | 2 | 5 | 8 | 2 | |
| Other liabilities | 24 | 25 | 33 | 47 | 32 | |
| Total liabilities | 279 | 431 | 562 | 695 | 707 | |
| Commitments and contingencies (Note 20) | — | — | — | — | — | |
| Redeemable non-controlling interest | 2 | 2 | 2 | 2 | 0 | |
| Preferred stock, 5,000 shares authorized; no par value; no shares issued and outstanding as of December 31, 2025 and 2024 | 0 | 0 | — | — | — | |
| Common stock, $0.001 par value, authorized 220,000 shares; shares issued 145,581 and 135,510 as of December 31, 2025 and 2024, respectively | 146,000 | 136,000 | 134,000 | 131,000 | 128,000 | |
| Additional paid-in capital | 1,620 | 1,593 | 1,578 | 1,548 | 1,501 | |
| Accumulated deficit | −1,332 | −1,362 | −1,107 | −744 | −621 | |
| Accumulated other comprehensive loss | −48 | −55 | −44 | −54 | −38 | |
| Total stockholders equity | 240 | 176 | 427 | 750 | — | |
| Total liabilities, redeemable non-controlling interest and stockholders equity | 522 | 609 | 991 | 1,447 | 1,549 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 22 | 33 | 33 | 36 | 35 | |
| Accretion of debt discount | 1 | 1 | 3 | 3 | — | |
| Stock-based compensation | 10 | 18 | 24 | 42 | 55 | |
| Loss on short-term investments | 0 | 0 | 6,000 | 3 | 0 | |
| Non-cash operating lease expense | 10 | 10 | 9 | 6 | 6 | |
| Provision for inventory obsolescence and revaluation | 8 | 12 | 6 | 3 | −3 | |
| Provision for bad debts | 2 | 506,000 | 595,000 | 562,000 | 232,000 | |
| (Gain) loss on the disposition of businesses, property, equipment and other assets | −139 | 3 | 6,000 | 104,000 | −351 | |
| Gain on debt extinguishment | −5 | −22 | −32 | 0 | 0 | |
| Benefit for deferred income taxes and reserve adjustments | −685,000 | −952,000 | −2 | −3 | −12 | |
| Asset impairment charges | 760,000 | 145 | 305 | 4 | — | |
| Accounts receivable | 18 | −6 | −6 | 8 | −12 | |
| Inventories | −14 | 16 | −21 | −51 | 8 | |
| Prepaid expenses and other current assets | 698,000 | 7 | −8 | 8 | −8 | |
| Accounts payable | −3 | −6 | −6 | −4 | 27 | |
| Deferred revenue and customer deposits | −8 | 4 | 1 | −7 | −3 | |
| Accrued and other liabilities | −5 | −6 | −13 | 11 | −12 | |
| All other operating activities | −19 | −2 | −13 | −8 | −6 | |
| Net cash used in operating activities | −88 | −45 | −81 | −70 | 48 | |
| Purchases of property and equipment | −10 | −16 | −27 | −21 | −19 | |
| Sales and maturities of short-term investments | 0 | 0 | 181 | 200 | 0 | |
| Proceeds from sale of assets and businesses, net of cash sold | 123 | 96,000 | 194,000 | 325,000 | 421 | |
| Acquisitions and other investments, net of cash acquired | −4 | −3 | −29 | −104 | −140 | |
| Other investing activities | 186,000 | 0 | 0 | 0 | −2 | |
| Net cash provided by (used in) investing activities | 109 | −19 | 125 | −308 | 261 | |
| Proceeds from borrowings | 92 | 0 | 0 | 0 | 460 | |
| Debt issuance and amendment costs | −6 | 0 | 0 | 0 | −13 | |
| Repayment of borrowings and long-term debt | −170 | −87 | −101 | 0 | −21 | |
| Stock repurchases | −15 | 0 | 0 | — | — | |
| Taxes paid related to net-share settlement of equity awards | −1 | −3 | −5 | −11 | −13 | |
| Other financing activities | −2 | −1 | −644,000 | −651,000 | −423,000 | |
| Net cash used in financing activities | −102 | −91 | −106 | −14 | 406 | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 5 | −5 | 4 | −6 | −9 | |
| Net decrease in cash, cash equivalents and restricted cash | −76 | −160 | −59 | −398 | 705 | |
| Lease assets obtained in exchange for new lease liabilities | 3 | 7 | 38 | 6 | 5 | |
| Cash interest payments | 4 | 1 | 478,000 | 196,000 | 1 | |
| Cash income tax payments, net | 10 | 6 | 4 | 5 | 5 | |
| Transfer of equipment from inventory to property and equipment, net | 4 | 2 | 2 | −2 | 2 | |
| Exchange of NAMI trade receivables for loan receivable | 0 | 2 | 0 | — | — | |
| Exchange of assets for investment | 1 | 0 | 0 | — | — | |
| Conversion of debt to equity | 31 | 0 | 0 | — | — | |
| Shares issued as debt issuance costs | 1 | 0 | 0 | — | — |